News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
44,711 Results
Type
Article (3550)
Company Profile (26)
Press Release (41135)
Section
Business (14038)
Career Advice (55)
Deals (1768)
Drug Delivery (7)
Drug Development (3804)
Employer Resources (3)
FDA (580)
Job Trends (1246)
News (19824)
Policy (1344)
Tag
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (1)
2024 Genetown Digital (1)
2024 Genetown Standard (1)
2024 Pharm Country Digital (1)
Academia (428)
Allergies (7)
Alliances (5593)
ALS (8)
Alzheimer's disease (59)
Antibody-drug conjugate (ADC) (3)
Approvals (582)
Artificial intelligence (36)
Autoimmune disease (2)
Automation (7)
Bankruptcy (15)
Best Places to Work (1103)
BIOSECURE Act (12)
Biosimilars (1)
Biotechnology (24)
Bladder cancer (8)
Brain cancer (3)
Breast cancer (47)
Cancer (293)
Cardiovascular disease (9)
Career advice (55)
Career pathing (1)
CAR-T (8)
Cell therapy (46)
Cervical cancer (1)
Clinical research (2672)
Collaboration (123)
Compensation (20)
Complete response letters (1)
COVID-19 (199)
CRISPR (18)
C-suite (15)
Cystic fibrosis (7)
Data (187)
Diabetes (13)
Diagnostics (1403)
Digital health (1)
Diversity, equity & inclusion (1)
Drug discovery (12)
Drug pricing (1)
Duchenne muscular dystrophy (5)
Earnings (3367)
Editorial (1)
Employer branding (1)
Employer resources (3)
Events (6349)
Executive appointments (71)
FDA (636)
Featured Employer (5)
Funding (49)
Gene editing (49)
Generative AI (3)
Gene therapy (49)
GLP-1 (34)
Government (291)
Guidances (7)
Healthcare (1219)
Huntington's disease (2)
Immunology and inflammation (3)
Infectious disease (209)
Inflammatory bowel disease (10)
Influenza (5)
Intellectual property (8)
Interviews (4)
IPO (772)
Job creations (178)
Job search strategy (52)
Layoffs (17)
Legal (206)
Liver cancer (7)
Lung cancer (47)
Lymphoma (11)
Machine learning (2)
Management (1)
Manufacturing (26)
MASH (1)
Medical device (335)
Medtech (336)
Mergers & acquisitions (1026)
Metabolic disorders (21)
NASH (1)
Neurodegenerative disease (7)
Neuropsychiatric disorders (1)
Neuroscience (90)
NextGen: Class of 2025 (381)
Non-profit (292)
Northern California (277)
Now hiring (2)
Obesity (5)
Opinion (27)
Ovarian cancer (2)
Pain (4)
Pancreatic cancer (11)
Parkinson's disease (9)
Partnered (1)
Patents (10)
Patient recruitment (4)
Peanut (5)
People (4424)
Pharmaceutical (2)
Phase I (1177)
Phase II (1260)
Phase III (824)
Pipeline (71)
Policy (15)
Postmarket research (42)
Preclinical (658)
Press Release (22)
Prostate cancer (10)
Radiopharmaceuticals (3)
Rare diseases (37)
Real estate (351)
Regulatory (964)
Reports (3)
Research institute (512)
Resumes & cover letters (2)
RSV (1)
Schizophrenia (1)
Series A (11)
Series B (5)
Sickle cell disease (14)
Southern California (239)
Spinal muscular atrophy (2)
Sponsored (2)
Startups (362)
Supply chain (5)
United States (1818)
Vaccines (22)
Venture capitalists (2)
Weight loss (4)
Date
Today (13)
Last 7 days (72)
Last 30 days (193)
Last 365 days (2522)
2025 (735)
2024 (2786)
2023 (3244)
2022 (4361)
2021 (4534)
2020 (3868)
2019 (2933)
2018 (2187)
2017 (2508)
2016 (2406)
2015 (2488)
2014 (1610)
2013 (1393)
2012 (1416)
2011 (1401)
2010 (1236)
Location
Africa (57)
Alabama (8)
Alaska (1)
Arizona (22)
Asia (2264)
Australia (353)
California (645)
Canada (81)
China (44)
Colorado (12)
Connecticut (32)
Delaware (7)
Europe (5771)
Florida (61)
Georgia (4)
Idaho (1)
Illinois (20)
India (3)
Indiana (9)
Iowa (4)
Japan (17)
Kansas (2)
Kentucky (1)
Louisiana (1)
Maine (3)
Maryland (63)
Massachusetts (381)
Michigan (13)
Minnesota (18)
Missouri (7)
Montana (2)
Nebraska (5)
Nevada (5)
New Hampshire (2)
New Jersey (88)
New Mexico (11)
New York (81)
North Carolina (124)
North Dakota (6)
Northern California (277)
Ohio (19)
Oregon (2)
Pennsylvania (47)
Rhode Island (3)
South America (59)
South Carolina (2)
Southern California (239)
Tennessee (3)
Texas (97)
Utah (23)
Virginia (6)
Washington D.C. (4)
Washington State (37)
Wisconsin (10)
44,711 Results for "cofactor genomics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Cofactor Genomics Announces the Expansion of OncoPrism into Colorectal, Breast, Bladder, and Kidney Cancer
March 6, 2025
·
3 min read
Press Releases
Precision Medicine Global Thought Leader, Dr. Howard McLeod, Joins Cofactor Genomics’ Advisory Board as Cofactor Brings OncoPrism test to Partnered Hospitals
October 29, 2024
·
2 min read
Press Releases
Cofactor Genomics Publishes Clinical Validation of OncoPrism-HNSCC, a Test Leveraging Novel RNA Modeling Technology to Predict Response to Immunotherapy
November 7, 2024
·
2 min read
Press Releases
Cofactor Genomics receives Medicare coverage for OncoPrism®, a machine learning-based RNA oncology test predicting immunotherapy response
October 21, 2024
·
1 min read
Press Releases
Sentynl Therapeutics Announces First Comprehensive Body of Clinical Evidence Supporting NULIBRY® (fosdenopterin) in Treating Molybdenum Cofactor Deficiency Type A Compared to Natural History
April 2, 2025
·
7 min read
Press Releases
Cofactor Genomics expands clinical use of OncoPrism, as their AI enabled RNA test achieves national clinical validation after predicting immunotherapy response in Lung Cancer Patients
November 15, 2024
·
2 min read
BioMidwest
Cofactor Genomics’ Immunotherapy Predictive Diagnostic, OncoPrism, Completes Validation and Moves Into Clinical Use in Head and Neck Cancer Patients
Cofactor Genomics, the company bridging the precision medicine gap, today announced successful validation of the OncoPrism immunotherapy predictive diagnostic assay, enabling physicians to use the test to help guide treatment decisions for patients with metastatic or recurrent squamous cell carcinoma of the head and neck (HNSCC).
November 17, 2023
·
2 min read
Business
Stanford University Joins Cofactor Genomics’ Clinical Trial Evaluating Immunotherapy Predictive Diagnostic Assay Across 11 Cancers
Stanford University and Cofactor Genomics, the company bridging the precision medicine gap, announced that Stanford will join Cofactor’s PREDAPT clinical trial evaluating use of the company’s OncoPrism™ predictive diagnostic assay across 11 cancers.
July 11, 2023
·
2 min read
Business
Culmination Bio and Cofactor Genomics Leverage Largest Biobank in the U.S. for PREDAPT Precision Medicine Clinical Trial
Culmination Bio today announced a partnership to leverage samples and data from one of the largest biobanks in the country to fuel the development of Cofactor Genomic’s OncoPrism™ test in 11 cancers.
May 9, 2023
·
3 min read
Press Releases
Moss Genomics Launches “Perennial” Genomics Platform, Closes on 130 ETH
April 28, 2025
·
7 min read
1 of 4,472
Next
